278 related articles for article (PubMed ID: 28494643)
1. Randomised clinical trial of early specialist palliative care plus standard care versus standard care alone in patients with advanced cancer: The Danish Palliative Care Trial.
Groenvold M; Petersen MA; Damkier A; Neergaard MA; Nielsen JB; Pedersen L; Sjøgren P; Strömgren AS; Vejlgaard TB; Gluud C; Lindschou J; Fayers P; Higginson IJ; Johnsen AT
Palliat Med; 2017 Oct; 31(9):814-824. PubMed ID: 28494643
[TBL] [Abstract][Full Text] [Related]
2. Exploratory analyses of the Danish Palliative Care Trial (DanPaCT): a randomized trial of early specialized palliative care plus standard care versus standard care in advanced cancer patients.
Johnsen AT; Petersen MA; Sjøgren P; Pedersen L; Neergaard MA; Damkier A; Gluud C; Fayers P; Lindschou J; Strömgren AS; Nielsen JB; Higginson IJ; Groenvold M
Support Care Cancer; 2020 May; 28(5):2145-2155. PubMed ID: 31410598
[TBL] [Abstract][Full Text] [Related]
3. A randomised, multicentre clinical trial of specialised palliative care plus standard treatment versus standard treatment alone for cancer patients with palliative care needs: the Danish palliative care trial (DanPaCT) protocol.
Johnsen AT; Damkier A; Vejlgaard TB; Lindschou J; Sjøgren P; Gluud C; Neergaard MA; Petersen MA; Lundorff LE; Pedersen L; Fayers P; Strömgren AS; Higginson IJ; Groenvold M
BMC Palliat Care; 2013 Oct; 12(1):37. PubMed ID: 24152880
[TBL] [Abstract][Full Text] [Related]
4. Detailed statistical analysis plan for the Danish Palliative Care Trial (DanPaCT).
Johnsen AT; Petersen MA; Gluud C; Lindschou J; Fayers P; Sjøgren P; Pedersen L; Neergaard MA; Vejlgaard TB; Damkier A; Nielsen JB; Strömgren AS; Higginson IJ; Groenvold M
Trials; 2014 Sep; 15():376. PubMed ID: 25257804
[TBL] [Abstract][Full Text] [Related]
5. Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial.
Vanbutsele G; Pardon K; Van Belle S; Surmont V; De Laat M; Colman R; Eecloo K; Cocquyt V; Geboes K; Deliens L
Lancet Oncol; 2018 Mar; 19(3):394-404. PubMed ID: 29402701
[TBL] [Abstract][Full Text] [Related]
6. Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis.
Gaertner J; Siemens W; Meerpohl JJ; Antes G; Meffert C; Xander C; Stock S; Mueller D; Schwarzer G; Becker G
BMJ; 2017 Jul; 357():j2925. PubMed ID: 28676557
[No Abstract] [Full Text] [Related]
7. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
8. Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.
Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
BMC Palliat Care; 2020 Jun; 19(1):81. PubMed ID: 32517678
[TBL] [Abstract][Full Text] [Related]
9. Which symptoms and problems do advanced cancer patients admitted to specialized palliative care report in addition to those included in the EORTC QLQ-C15-PAL? A register-based national study.
Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
Support Care Cancer; 2020 Apr; 28(4):1725-1735. PubMed ID: 31297593
[TBL] [Abstract][Full Text] [Related]
10. Effect of an Oncology Nurse-Led Primary Palliative Care Intervention on Patients With Advanced Cancer: The CONNECT Cluster Randomized Clinical Trial.
Schenker Y; Althouse AD; Rosenzweig M; White DB; Chu E; Smith KJ; Resick JM; Belin S; Park SY; Smith TJ; Bakitas MA; Arnold RM
JAMA Intern Med; 2021 Nov; 181(11):1451-1460. PubMed ID: 34515737
[TBL] [Abstract][Full Text] [Related]
11. Early palliative care for adults with advanced cancer.
Haun MW; Estel S; Rücker G; Friederich HC; Villalobos M; Thomas M; Hartmann M
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011129. PubMed ID: 28603881
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
[TBL] [Abstract][Full Text] [Related]
13. Early, integrated palliative rehabilitation improves quality of life of patients with newly diagnosed advanced cancer: The Pal-Rehab randomized controlled trial.
Nottelmann L; Groenvold M; Vejlgaard TB; Petersen MA; Jensen LH
Palliat Med; 2021 Jul; 35(7):1344-1355. PubMed ID: 34000886
[TBL] [Abstract][Full Text] [Related]
14. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module. European Organization for Research and Treatment of Cancer.
Stockler MR; Osoba D; Goodwin P; Corey P; Tannock IF
J Clin Epidemiol; 1998 Feb; 51(2):137-45. PubMed ID: 9474074
[TBL] [Abstract][Full Text] [Related]
17. Identifying health-related quality of life cut-off scores that indicate the need for supportive care in young adults with cancer.
Lidington E; Giesinger JM; Janssen SHM; Tang S; Beardsworth S; Darlington AS; Starling N; Szucs Z; Gonzalez M; Sharma A; Sirohi B; van der Graaf WTA; Husson O
Qual Life Res; 2022 Sep; 31(9):2717-2727. PubMed ID: 35476170
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
19. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care.
Groenvold M; Petersen MA; Aaronson NK; Arraras JI; Blazeby JM; Bottomley A; Fayers PM; de Graeff A; Hammerlid E; Kaasa S; Sprangers MA; Bjorner JB;
Eur J Cancer; 2006 Jan; 42(1):55-64. PubMed ID: 16162404
[TBL] [Abstract][Full Text] [Related]
20. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
